Cite
HARVARD Citation
He, D. et al. (2019). A multicenter observational study of the real‐world use of docetaxel for metastatic castration‐resistant prostate cancer in China. Asia-Pacific journal of clinical oncology. 15 (3), pp. 144-150. [Online].